Back
Pacira BioSciences Vs. Revance Therapeutics Industry Stock Comparison
Sell
33
PCRX
Pacira BioSciences
Last Price:
14.50
Seasonality Move:
-2.82%
Sell
20
RVNC
Revance Therapeutics
Last Price:
5.82
Seasonality Move:
-10.6%
Sell
33
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $14.52. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $5.81. The Score for RVNC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $14.52
The current trend is relatively stagnant and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $5.81
The current trend is moderately bearish and RVNC is experiencing slight selling pressure.
PCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 46.94 | Sell |
Chaikin Money Flow: | -1701132 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.35 - 14.93) | Buy |
Bollinger Bands (100): | (15.74 - 28.84) | Sell |
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 43.04 | Sell |
Chaikin Money Flow: | -820630 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.18 - 6.72) | Sell |
Bollinger Bands (100): | (2.61 - 5.71) | Buy |
PCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.81 | Buy |
20-day SMA: | 14.24 | Buy |
50-day SMA: | 16.6 | Sell |
200-day SMA: | 26.16 | Sell |
8-day EMA: | 14.17 | Buy |
20-day EMA: | 14.41 | Buy |
50-day EMA: | 16.86 | Sell |
200-day EMA: | 24.76 | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.16 | Sell |
20-day SMA: | 6.41 | Sell |
50-day SMA: | 5.27 | Buy |
200-day SMA: | 5.03 | Buy |
8-day EMA: | 6.08 | Sell |
20-day EMA: | 6.14 | Sell |
50-day EMA: | 5.45 | Buy |
200-day EMA: | 6.57 | Sell |
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.00 per share.
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
Pacira BioSciences Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Revance Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |